Kimia Biosciences [KIMIABL] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Kimia Biosciences Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kimia Biosciences Ltd. wins in 3 metrics, Divi's Laboratories Ltd. wins in 9 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kimia Biosciences Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) N/A 67.11 N/A
Price-to-Book Ratio 15.97 10.82 Divi's Laboratories Ltd.
Debt-to-Equity Ratio 311.45 0.58 Divi's Laboratories Ltd.
PEG Ratio N/A 4.63 N/A
EV/EBITDA 10.88 48.63 Kimia Biosciences Ltd.
Profit Margin (TTM) 7.19% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 18.95% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 18.95% 29.65% Divi's Laboratories Ltd.
Return on Equity N/A 14.64% N/A
Return on Assets (TTM) N/A 12.94% N/A
Free Cash Flow (TTM) N/A $2.15B N/A
Dividend Yield N/A 0.91% N/A
1-Year Return -26.63% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.44 16.18 Kimia Biosciences Ltd.
Enterprise Value $2.10B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.67 15.86 Kimia Biosciences Ltd.
Gross Profit Margin (TTM) N/A 63.71% N/A
Revenue per Share (TTM) $27 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) N/A $93.66 N/A
Beta (Stock Volatility) 0.89 0.19 Divi's Laboratories Ltd.

Kimia Biosciences Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

KIMIABL
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kimia Biosciences Ltd.0.49%-9.12%-4.82%8.73%13.21%-6.14%
Divi's Laboratories Ltd.0.30%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kimia Biosciences Ltd.-26.63%2.24%-15.80%82.50%82.50%82.50%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Kimia Biosciences Ltd. vs Divi's Laboratories Ltd.

MetricKIMIABLDIVISLAB
Market Information
Market Cap i₹1.81B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,891253,443
90 Day Avg. Volume i7,027283,911
Last Close₹33.00₹6,596.50
52 Week Range₹23.20 - ₹86.85₹5,636.50 - ₹7,071.50
% from 52W High-62.00%-6.72%
All-Time High₹86.85 (Jul 02, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-62.00%-6.72%
Growth Metrics
Quarterly Revenue Growth0.00%0.12%
Quarterly Earnings Growth0.19%-0.01%
Financial Health
Profit Margin (TTM) i0.07%0.24%
Operating Margin (TTM) i0.19%0.30%
Return on Equity (TTM) iN/A0.15%
Debt to Equity (MRQ) i311.450.58
Cash & Liquidity
Book Value per Share (MRQ)₹2.40₹580.95
Cash per Share (MRQ)₹0.15₹122.95
Operating Cash Flow (TTM) i₹0₹19.67B
Levered Free Cash Flow (TTM) i₹0₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Kimia Biosciences Ltd. vs Divi's Laboratories Ltd.

MetricKIMIABL (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) iN/A67.11
Forward P/E iN/A53.75
PEG Ratio iN/A4.63
Price to Sales (TTM) i1.4416.18
Price to Book (MRQ) i15.9710.82
Market Capitalization
Market Capitalization i₹1.81B₹1.69T
Enterprise Value i₹2.10B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.6715.86
Enterprise to EBITDA i10.8848.63
Risk & Other Metrics
Beta i0.890.19
Book Value per Share (MRQ) i₹2.40₹580.95

Financial Statements Comparison: Kimia Biosciences Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKIMIABLDIVISLAB (2025)
Revenue/Sales iN/A93.25B
Cost of Goods Sold iN/A38.70B
COGS % of Revenue i-41.5%
Gross Profit iN/A54.55B
Gross Margin i-58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) iN/A25.71B
Operating Margin i-27.6%
EBITDA iN/A33.19B
EBITDA Margin i-35.6%
Pre-Tax Income iN/A29.16B
Pre-Tax Income % of Revenue i-31.3%
Income Tax iN/A7.25B
Income Tax % of Revenue i-7.8%
Net Income (Profit) iN/A21.91B
Profit Margin i-23.5%

Balance Sheet & Liquidity Metrics

MetricKIMIABLDIVISLAB (2025)
Cash & Equivalents iN/A4.15B
Total Current Assets iN/A100.81B
Total Current Assets % of Revenue i-108.1%
Total Current Liabilities iN/A14.52B
Total Current Liabilities % of Revenue i-15.6%
Long-Term Debt iN/A20.00M
Long-Term Debt % of Revenue i-0.0%
Total Shareholders Equity iN/A149.69B
Retained Earnings iN/A134.00B
Retained Earnings % of Revenue i-143.7%
Property, Plant & Equipment iN/A3.19B

Cash Flow Statement Comparison

MetricKIMIABLDIVISLAB (2025)
Operating Cash Flow iN/A19.67B
Operating Cash Flow % of Revenue i-21.1%
Capital Expenditures iN/A-14.38B
Free Cash Flow iN/A2.15B
FCF Margin i-2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKIMIABLDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i47.31M265.47M
Float Shares i2.55M117.72M
% Held by Insiders i91.00%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i9.00%19.31%

Dividend Analysis & Yield Comparison: Kimia Biosciences Ltd. vs Divi's Laboratories Ltd.

MetricKIMIABLDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025